Your AI-Trained Oncology Knowledge Connection!
Video
Author(s):
An overview of the ZUMA-7 and the TRANSFORM trial as well as reviewing eligibility criteria for patients who might receive CAR-T therapy.
Apr 8th 2025 - May 14th 2025
Apr 7th 2025 - Apr 8th 2026
Apr 3rd 2025 - May 9th 2025
Apr 17th 2025 - May 23rd 2025
Apr 17th 2025 - May 23rd 2025
Apr 8th 2025 - May 14th 2025
Apr 7th 2025 - Apr 8th 2026
Apr 3rd 2025 - May 9th 2025
Apr 17th 2025 - May 23rd 2025
Apr 17th 2025 - May 23rd 2025
Apr 8th 2025 - May 14th 2025
Apr 7th 2025 - Apr 8th 2026
Apr 3rd 2025 - May 9th 2025
Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of R/R MM
Application of Real-World Evidence in Selecting CAR T in R/R MM
Addition of Daratumumab to Lenalidomide Maintenance Boosts MRD-Negative Conversions in Myeloma Following ASCT
Apalutamide Boosts 24-Month OS in Real-World Population With Metastatic Castration-Sensitive Prostate Cancer
2 Commerce Drive
Cranbury, NJ 08512